A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study

BACKGROUND: The study investigated whether donepezil exerts symptomatic benefit in patients with posterior cortical atrophy (PCA), an atypical variant of Alzheimer’s disease. METHODS: A single-centre, double-blind, placebo-controlled, cross-over clinical trial was performed to assess the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridha, Basil H., Crutch, Sebastian, Cutler, Dawn, Frost, Christopher, Knight, William, Barker, Suzie, Epie, Norah, Warrington, Elizabeth K., Kukkastenvehmas, Riitta, Douglas, Jane, Rossor, Martin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930935/
https://www.ncbi.nlm.nih.gov/pubmed/29716655
http://dx.doi.org/10.1186/s13195-018-0363-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930935/
https://www.ncbi.nlm.nih.gov/pubmed/29716655
http://dx.doi.org/10.1186/s13195-018-0363-1

Ejemplares similares